Multisite Validation Study to Determine Performance Characteristics of a 92-Gene Molecular Cancer Classifier

Sarah E. Kerr, Catherine A. Schnabel, Peggy Sullivan, Yi Zhang, Veena Singh, Brittany Carey, Mark G. Erlander, W. Edward Highsmith, Sarah Dry, Elena F. BrachtelClinical 2012 · DOI

Abstract

The 92-gene assay showed strong performance for accurate molecular classification of a diverse set of tumor histologies. Results support potential use of the assay as a standardized molecular adjunct to routine clinicopathologic evaluation for tumor classification and primary site diagnosis.
BibTeX
@inproceedings{kerr2012multisite,
  author = {Sarah E. Kerr and Catherine A. Schnabel and Peggy Sullivan and Yi Zhang and Veena Singh and Brittany Carey and Mark G. Erlander and W. Edward Highsmith and Sarah Dry and Elena F. Brachtel},
  title = {{Multisite Validation Study to Determine Performance Characteristics of a 92-Gene Molecular Cancer Classifier}},
  booktitle = {Clinical},
  year = {2012},
  doi = {10.1158/1078-0432.ccr-12-0920},
}

Loading related content...

Figure